Celularity Inc
CELUW
12 hedge funds and large institutions have $83.9K invested in Celularity Inc in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.03% less ownership
Funds ownership: 16.21% → 16.18% (-0.03%)
22% less capital invested
Capital invested by funds: $107K → $83.9K (-$23.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$482 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$64 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$722 |
CELUW Hedge Fund Activity: Q3 2025 in Review
12 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Celularity Inc (CELUW) for Q3 2025, worth a combined $83.9K — down 22% from $107K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CELUW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Securities, adding an estimated $482. The largest seller was Walleye Capital, cutting an estimated $722.
- 12 institutional investors held Celularity Inc (CELUW) as of Q3 2025, up from 11 in Q2 2025.
- Funds reported $83.9K of Celularity Inc stock for Q3 2025, down 22% quarter-over-quarter.
- 1 fund opened new Celularity Inc positions in Q3 2025 and 0 closed out, a net change of +1 holder.
- The largest Celularity Inc buyer in Q3 2025 was Two Sigma Securities, an estimated $482 added.
- The largest Celularity Inc seller in Q3 2025 was Walleye Capital, an estimated $722 sold.
Based on aggregated 13F filings for Q3 2025.